User

Effect of Antenatal Mental Health Disorder on Fetal Growth: A Systematic Review

Rina Tri Handayani, Aris Widiyanto, Joko Tri Atmojo, Catur Setyorini

Abstract

Background: Maternal mental disorders during pregnancy are associated with a range of adverse health outcomes for infants. Re­cent studies indi­cate the possible mechanism of maternal mental health disorders asso­ciated with fetal develop­ment through prog­ram­­ming effect. This study aimed to sys­tema­t­ically review the effect of ante­natal mental health disorders on fetal growth.

Subjects and Method: This was a sys­tem­atic review. The articles were selected from Psyc­INFO, Medline, Web of Science, Em­­­base, and PubMed journal databases pu­blis­hed from July to Septem­ber 2018. The keywords for this review included maternal mental health AND fetal growth, post­partum de­p­ress­­ion AND fetal growth, maternal mental health AND fetal growth AND review. As many as 11 articles were selected for this stu­dy from 575 articles.

Results: Maternal mental health during preg­nancy was associated with fetal head cir­cum­­ference growth through 2 mechanism: (1) In­creased maternal stress response modifies neu­ro­en­docrine function, which included changes in cortisol regulation, adreno­corti­co­tropic, adrena­line and nor­adrenaline hor­mo­nes levels; and (2) Decreased 11β-hydroxy­steroid dehydrogenase (11β-HSD2) enzyme regulation in placenta. It decreased11β-HSD2 level, increa­s­ed fetal gluco­corticoids circu­la­tion, and affect­ed on fetal head growth restriction.

Conclusion: Maternal mental health during pregnancy is associated with fetal head circ­um­­fe­rence growth restriction.

Keywords: maternal mental health, fetal head circumference, growth, systematic re­view

Correspondence: Rina Tri Handayani. School of Health Scien­ces Mamba'ul 'Ulum, Surakarta, Jl. Ring Road Utara, Tawangsari, Mojosongo, Jebres, Sura­­ka­r­ta, Cen­tral Java. Email: trihandayan­ir­ina­@gmail­.­com: 085642224141

Journal of Maternal and Child Health (2020), 5(2): 147-153
https://doi.org/10.26911/thejmch.2020.05.02.04


Full Text:

PDF

References

Achard V, Boullu C S, Desbriére R, Grino M(2006). Perinatal programming of central obesity and the metabolic syndrome: Role of glucocorticoids. Metabolic Syndrome and Related Disorders. 4(2):129-37. doi: 10.1089/met.2006.4.129 [Crossref] [PubMed] [Google Scholar]


American Psychiatric Association (2013) Diagnostic statistical manual of mental disorders. American Journal of Psychiatry. https://doi.org/10.1176/appi.books.9780890425596


Baschat AA (2011). Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound in Obstetrics and Gynecology. 37(5):501-14. doi: 10.1002/uog.9008 [Crossref] [PubMed] [Google Scholar]


Bennett H, Einarson A, Taddio A, Koren G, Einarson TR (2004). Prevalence of depression during pregnancy: Systematic review. Obstetrics and Gynecology. 103(4):698-709. doi: 10.1097/01.aog.0000116689.75396.5f [Crossref] [PubMed] [Google Scholar]


Das UG, Sysyn GD (2004). Abnormal fetal growth: Intrauterine growth retardation, small for gestational age, large for gestational age. Pediatric Clinics of North America. 51(3): 639-54. doi: 10.1016/j.pcl.2004.01.004 [Crossref] [PubMed] [Google Scholar]


Diego MA, Jones NA, Field T, Hernandez RM, Schanberg S, Kuhn C, Gonzalez GA (2006). Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosomatic Medicine. 68(5): 747-53. doi: 10.1097/01.psy.0000238212.21598.7b [Crossref] [PubMed] [Google Scholar]


Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC (2005). Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evidence report/technology assessment (Summary). (119): 1-8. [PubMed] [Google Scholar]


Howard LM, Molyneaux E, Dennis CL, Rochat T, Stein A, Milgrom J (2014). Non-psychotic mental disorders in the perinatal period. The Lancet. 384(9956):1775-88. doi: 10.1016/s0140-6736(14)61276-9 [Crossref] [Google Scholar]


Lee AM, Lam SK, Sze ML, Stephanie MC, Catherine SY, Chui HW, Fong DYT (2007). Prevalence, course, and risk factors for antenatal anxiety and depression. Obstetrics and Gynecology. 110(5): 1102-12. doi: 10.1097/01.aog.0000287065.59491.70 [Crossref] [PubMed] [Google Scholar]


Lewis A, Austin E, Knapp R, Vaiano T, Galbally M (2015). Perinatal Maternal Mental Health, Fetal Programming and Child Development. Healthcare, 3(4): 1212–1227. doi: 10.3390/healthcare3041212 [Crossref] [PubMed] [Google Scholar]


Lewis AJ, Austin E, Galbally M (2016). Prenatal maternal mental health and fetal growth restriction: a systematic review. Journal of Developmental Origins of Health and Disease, 7(04): 416–428. doi: 10.1017/s2040174416000076 [Crossref] [PubMed] [Google Scholar]


Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ.

(1): b2700–b2700. doi: 10.1136/bmj.b2700 [Crossref] [PubMed] [Google Scholar]


NiL, Pan, Yibin T, Chao X, Wenyi W, Ximei Z, Chaochun (2018). Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydro-genase type 2 expression and the adult metabolic disorders in mice. PLoS ONE, 13(9): 1–15. doi: 10.1371/journal.pone.0203802 [Crossref] [PubMed] [Google Scholar]


Quinkler M, Oelkers W, Diederich S (2001). Clinical implications of glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenases in target tissues. European Journal of Endocrinology. 144(2): 87-97. doi: 10.1530/eje.0.1440087 [Crossref] [PubMed] [Google Scholar]


Seth S, Lewis AJ, Saffery R, Lappas M, Galbally M (2015). Maternal prenatal mental health and placental 11β-HSD2 gene expression: Initial findings from the mercy pregnancy and emotionalwellbeing study. International Journal of Molecular Sciences. 16(11):27482-96. doi: 10.3390/ijms161126034 [Crossref] [PubMed] [Google Scholar]


Seckl JR, Holmes MC (2007). Mechanisms of disease: Glucocorticoids, their placental metabolism and fetal”programming”of adult pathophysiology. Nature Clinical Practice Endocrinology and Metabolism. 3(6):479-88. doi: 10.1038/ncpendmet0515 [Crossref] [PubMed] [Google Scholar]


Seng JS, Rauch SAM, Resnick H, Reed CD, King AL, Lisa K, McPherson M (2010). Exploring posttraumatic stress disorder symptom profile among pregnant women. Journal of Psychosomatic Obstetrics and Gynecology. 31(3):176-87. doi: 10.3109/0167482x.2010.486453 [Crossref] [PubMed] [Google Scholar]


Thompson A, Han VKM, Yang K (2004). Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development. Journal of Steroid Biochemistry and Molecular Biology. 88(4–5): 367-375. doi: 10.1016/j.jsbmb.2003.12.014 [Crossref] [PubMed] [Google Scholar]


Wächter R, Masarik L, Bürzle M, Mallik A, Von Mandach U (2009). Differential expression and activity of 11β-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction. Fetal Diagnosis and Therapy. 25: 328–335. doi: 10.1016/j.jsbmb.2003.12.014 [Crossref] [PubMed] [Google Scholar]


Wu G, Imhoff-Kunsch B, Girard AW (2012). Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatric and Perinatal Epidemiology. 26(1): 4-26. doi: 10.1111/j.1365-3016.2012.01291.x [Crossref] [PubMed] [Google Scholar]

Refbacks

  • There are currently no refbacks.